Résultat(s) 1 - 20 résultats de 27 pour la requête 'Akaza, H', Temps de recherche: 2,42s Affiner les résultats
  1. 1
    Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer
    Autres auteurs: “...Akaza, H...”
    Article

  2. 2
    A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9
    Autres auteurs: “...Akaza, H...”
    Article

  3. 3
    A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia focusing on improvement of I-PSS
    Autres auteurs: “...Akaza, H...”
    Article

  4. 4
    High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group
    Autres auteurs: “...Akaza, H...”
    Article

  5. 5
    Transurethral resection of benign prostatic hyperplasia using a vaporizing resecting loop, UROloop
    Autres auteurs: “...Akaza, H...”
    Article

  6. 6
    A case of synchronous multifocal urothelial tumors in a patient with phenacetin abuse
    Autres auteurs: “...Akaza, H...”
    Article

  7. 7
    Short- and long-term outcome after urethroplasty in the patients with hypospadias treated by Hodgson III method
    Autres auteurs: “...Akaza, H...”
    Article

  8. 8
    Clinical utility of the free prostate specific antigen (PSA), alpha 1-antichymotrypsin-complexed PSA, and free/total PSA ratio using the specific and sensitive enzyme-linked immunosorbent assay "E-plate EIKEN PSA"
    Autres auteurs: “...Akaza, H...”
    Article

  9. 9
    Phase I study of bicalutamide (Casodex), a nonsteroidal antiandrogen in patients with prostatic cancer
    Autres auteurs: “...Akaza, H...”
    Article

  10. 10
    Analysis of site differences in voiding condition of elderly men-- comparison to results of mass screening for prostate diseases between the villages of Shimamaki-mura, Hokkaido and Satomi-Mura, Ibaraki
    Autres auteurs: “...Akaza, H...”
    Article

  11. 11
    Clinical early phase II study of bicalutamide (Casodex) in patients with prostatic cancer
    Autres auteurs: “...Akaza, H...”
    Article

  12. 12
    Treatment of elderly patients with urological cancer
    Autres auteurs: “...Akaza, H...”
    Article

  13. 13
    Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study
    Autres auteurs: “...Akaza, H...”
    Article

  14. 14
    Phase I study of flutamide, a nonsteroidal antiandrogen, in patients with prostatic cancer
    Autres auteurs: “...Akaza, H...”
    Article

  15. 15
    Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors
    Autres auteurs: “...Akaza, H...”
    Article

  16. 16
    Clinical study of RU 23908 (nilutamide) in prostatic cancer
    Article

  17. 17
    Clinical phase III study on TAP-144-SR, an LH-RH agonist depot formulation, in patients with prostatic cancer
    Autres auteurs: “...Akaza, H...”
    Article

  18. 18
    Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR
    Autres auteurs: “...Akaza, H...”
    Article

  19. 19
    Trends in patterns of care for prostatic cancer in Japan statistics of 9 institutions for 5 years
    Autres auteurs: “...Akaza, H...”
    Article

  20. 20
    Clinical efficacy of long-term treatment with LH-RH analogue, ICI 118630 (Zoladex), in prostatic cancer patients. The Zoladex Multicenter Study Group
    Autres auteurs: “...Akaza, H...”
    Article

Outils de recherche: S'abonner aux flux RSS — Envoyer cette recherche par courriel